WELLS FARGO & COMPANY/MN - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 9 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q4 2022$1232000.0%0.00%
Q3 2022$0
-100.0%
2000.0%0.00%
Q2 2022$1,000
-75.0%
200
-60.0%
0.00%
Q1 2022$4,0000.0%5000.0%0.00%
Q4 2021$4,000
-33.3%
5000.0%0.00%
Q3 2021$6,000
-75.0%
500
-82.1%
0.00%
Q4 2020$24,000
+71.4%
2,800
+40.0%
0.00%
Q3 2020$14,0002,0000.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Atom Investors LP 99,180$857,0000.09%
HighPoint Advisor Group LLC 32,435$368,0000.04%
Transform Wealth, LLC 106,245$95,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 19,600$170,0000.00%
Renaissance Technologies 79,625$688,0000.00%
TRUIST FINANCIAL CORP 35,260$304,0000.00%
UBS Group AG 2,851$25,0000.00%
BREWIN DOLPHIN LTD 32$2760.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 2,800$24,0000.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders